NCT01435902View on ClinicalTrials.gov

A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2012

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Asthma
Interventions
DRUG

Fluticasone Furoate/Vilanterol Inhalation Powder

Fluticasone furoate/Vilanterol inhalation powder inhaled orally once daily for 4 weeks

DRUG

Fluticasone Propionate Inhalation Powder

Fluticasone propionate inhalation powder inhaled orally twice daily for 4 weeks

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01435902 - A Study of a New Asthma Medicine in Asthmatics Whose Asthma Worsens With Exercise | Biotech Hunter | Biotech Hunter